期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Australian Journal of Advanced Nursing LetPub Score 5.2
50 ratings
Rate
Reputation 6.4 Influence 3.4 Speed 8.8 | ||||||||||||||||||||
期刊簡稱 | AUST J ADV NURS | ||||||||||||||||||||
ISSN | 0813-0531 | ||||||||||||||||||||
E-ISSN | 1447-4328 | ||||||||||||||||||||
h-index | 33 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 8.30%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.ajan.com.au/ | ||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Australian Nursing Federation | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | AUSTRALIA | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 1983 | ||||||||||||||||||||
每年文章數 | 18每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 3.17% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded Social Science Citation Index | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0813-0531%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Australian Journal of Advanced Nursing] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:58:15 評論於 Given the diversity and complexity of organisms, it is not a problem to produce different results and publish them, as scientific research itself allows and encourages questioning, supplementing, improving, and even overturning previous knowledge. When writing a paper, we need some strategies, focusing mainly on two points: truthfully presenting materials and methods, especially highlighting discrepancies with others, in detail; in the discussion section, do not avoid contradictions, compare similarities and differences with previous studies, and try to provide reasonable and effective explanations(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:47:32 評論於 The relationship between the results of this study and relevant theories; the limitations or shortcomings of your research; the practical significance and application value of this study; suggestions for future research(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 21:38:06 評論於 What can be discussed in a discussion?(0) 讚! | 八坂篷蔚 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 21:27:08 評論於 How do I handle it when my discussion results don't align with my previously published articles?(0) 讚! | 深渊兴业 |
作者: 无影建刚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-17 10:04:32 評論於 Did you win later?(0) 讚! | 无影建刚 |
作者: Bertha 領域: 医学 審稿時間: 4.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-13 15:30:10 評論於 Probably too cold, I doubt if there is no editorial review, no comments for reviewers for 3 months(0) 讚! | Bertha |
作者: 太虚康震 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-12 13:42:15 評論於 Review speed: 4.0 experience sharing: It is probably too niche. I suspect that there is no editor reviewing it. It has been three months and no one has given any feedback for review(0) 讚! | 太虚康震 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 17:30:50 評論於 As long as we can maintain the SCI source journals, that's all that matters. If the school starts using CiteScore for evaluation, there's nothing to worry about. On one hand, CiteScore includes a wider range of journals, so our journal will definitely be included. Additionally, it benefits smaller journals, so the disparity between journals won't be as drastic. I hope the school adopts CiteScore(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us